Descriptor English: | Ertapenem | ||||||
Descriptor Spanish: |
Ertapenem
| ||||||
Descriptor Portuguese: | Ertapenem | ||||||
Descriptor French: | Ertapénem | ||||||
Entry term(s): |
Ertapenem Sodium Invanoz Invanz |
||||||
Tree number(s): |
D02.065.589.099.124.225 D03.633.100.300.124.225 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077727 | ||||||
Scope note: | A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents |
||||||
Registry Number: | G32F6EID2H | ||||||
CAS Type 1 Name: | (4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | ||||||
Public MeSH Note: | 2019; ERTAPENEM was indexed under BETA-LACTAMS 2006-2018; and under LACTAMS 2002-2005 |
||||||
History Note: | 2019 (2002) |
||||||
DeCS ID: | 57734 | ||||||
Unique ID: | D000077727 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/03 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Ertapenem
- Preferred
Invanoz
- Narrower
Invanz
- Narrower
Ertapenem Sodium
- Narrower
Concept UI |
M0414190 |
Scope note | A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. |
Preferred term | Ertapenem |
Concept UI |
M0477785 |
Preferred term | Invanoz |
Concept UI |
M0477786 |
Preferred term | Invanz |
Concept UI |
M0477784 |
Preferred term | Ertapenem Sodium |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey